Macrogol and Electrolytes Paediatric Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

macrogol and electrolytes paediatric

teva pharma (new zealand) limited - macrogol 3350 6.5625 g;  ;  ; potassium chloride 0.0233 g; sodium bicarbonate 0.0893 g; sodium chloride 0.1754 g - powder for oral solution - 6.9 g - active: macrogol 3350 6.5625 g     potassium chloride 0.0233 g sodium bicarbonate 0.0893 g sodium chloride 0.1754 g excipient: colloidal silicon dioxide lemon lime flavour- me 170 orange flavour 301768 saccharin sodium - for the relief from constipation, treatment of chronic constipation. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by physical examination of abdomen and rectum.

Endopeg or. sol. Belgía - enska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

endopeg or. sol.

b. braun melsungen ag - sodium sulfate decahydrate 12,9 g/1000 ml - eq. sodium sulfate anhydrous 5,68 g/1000 ml; potassium chloride 0,75 g/1000 ml; macrogol 59 g/1000 ml; sodium chloride 1,46 g/1000 ml; sodium hydrogen carbonate 1,68 g/1000 ml - oral solution - macrogol 4000 59 mg/ml; potassium chloride 0.75 mg/ml; sodium sulfate 12.9 mg/ml; sodium bicarbonate 1.68 mg/ml; sodium chloride 1.46 mg/ml - macrogol, combinations

GOLYTELY Powder for Oral Solution 4000 Millilitre Írland - enska - HPRA (Health Products Regulatory Authority)

golytely powder for oral solution 4000 millilitre

golytely limited name changed - macrogol 3350 sodium sulfate anhydrous sodium bicarbonate sodium chloride potassium chloride - powder for oral solution - 4000 millilitre

MOVICOL Írland - enska - HPRA (Health Products Regulatory Authority)

movicol

primecrown 2010 ltd - macrogol 3350 ; sodium bicarbonate ; sodium chloride ; potassium chloride - powder for oral solution - 13.8 grams - macrogol, combinations

CosmoCol Half 6.9g powder for oral solution Malta - enska - Medicines Authority

cosmocol half 6.9g powder for oral solution

stirling anglian pharmaceuticals ltd hillington park innovation centre, 1 ainslie road, hillington park, glasgow g52 4ru, united - macrogol, sodium chloride, sodium hydrogen, carbonate, potassium chloride - powder for oral solution - macrogol 3350 6.563 gram(s) ; sodium chloride 0.1754 gram(s) ; sodium hydrogen carbonate 0.0893 gram(s) ; potassium chloride 0.0233 gram(s) - drugs for constipation

CosmoCol Paediatric 6.9g powder for oral solution Malta - enska - Medicines Authority

cosmocol paediatric 6.9g powder for oral solution

stirling anglian pharmaceuticals ltd hillington park innovation centre, 1 ainslie road, hillington park, glasgow g52 4ru, united - macrogol, sodium chloride, sodium hydrogen, carbonate, potassium chloride - powder for oral solution - macrogol 3350 6.563 gram(s) ; sodium chloride 0.1754 gram(s) ; sodium hydrogen carbonate 0.0893 gram(s) ; potassium chloride 0.0233 gram(s) - drugs for constipation

Movicol 13.8g sachet, powder for oral solution Írland - enska - HPRA (Health Products Regulatory Authority)

movicol 13.8g sachet, powder for oral solution

novalus healthcare limited - macrogol 3350; sodium bicarbonate; sodium chloride; potassium chloride - powder for oral solution - 13.8 gram(s) - macrogol, combinations

CREON 40,000 pancreatic extract 400 mg capsules bottle Ástralía - enska - Department of Health (Therapeutic Goods Administration)

creon 40,000 pancreatic extract 400 mg capsules bottle

viatris pty ltd - pancreatic extract, quantity: 400 mg (equivalent: protease, qty 1600 ph eur unit; equivalent: lipase, qty 40000 ph eur unit; equivalent: amylase, qty 25000 ph eur unit) - capsule, enteric - excipient ingredients: hypromellose phthalate; iron oxide red; titanium dioxide; sodium lauryl sulfate; macrogol 4000; triethyl citrate; iron oxide black; iron oxide yellow; dimeticone 1000; gelatin; cetyl alcohol - creon is indicated as pancreatic enzyme replacement in paediatric and adult patients with pancreatic exocrine insufficiency (pei). pancreatic exocrine insufficiency is often associated with, but not limited to: cystic fibrosis, chronic pancreatitis, pancreatic surgery, gastrointestinal bypass surgery (eg. bilroth ii gastroenterostomy), ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm)